Studying Lipids as Potential Biomarkers in Patients With Fabry Disease

CompletedOBSERVATIONAL
Enrollment

108

Participants

Timeline

Start Date

October 14, 2021

Primary Completion Date

April 28, 2024

Study Completion Date

April 28, 2024

Conditions
Fabry Disease
Interventions
OTHER

Lipidomics

Lipidomics is the large-scale study of lipids (fats and fat-like molecules) within biological systems. It involves identifying and quantifying the wide variety of lipids in cells, tissues, or organisms to understand their roles in metabolism, signaling, and disease. Lipidomics is a subfield of metabolomics and uses advanced analytical techniques, like mass spectrometry, to profile lipid molecules. It helps in studying how lipids contribute to cellular functions, disease development, and responses to therapies.

Trial Locations (3)

Unknown

Sahlgrenska University Hospital, Gothenburg

Karolinska University Hospital, Stockholm

Akademiska University Hospital, Uppsala

All Listed Sponsors
collaborator

Karolinska University Hospital

OTHER

collaborator

Uppsala University Hospital

OTHER

collaborator

Sahlgrenska University Hospital

OTHER

lead

Vastra Gotaland Region

OTHER_GOV

NCT05046379 - Studying Lipids as Potential Biomarkers in Patients With Fabry Disease | Biotech Hunter | Biotech Hunter